BioLight Life Sciences (BioLight Life Sciences) Cyclically Adjusted PB Ratio : (As of Apr. 27, 2024)

View and export this data going back to . Start your Free Trial

What is BioLight Life Sciences Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation

BioLight Life Sciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BioLight Life Sciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences Cyclically Adjusted PB Ratio Chart

BioLight Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cyclically Adjusted PB Ratio

Get a 7-Day Free Trial

0.14

0.08

0.10

BioLight Life Sciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cyclically Adjusted PB Ratio	Get a 7-Day Free Trial															0.14	-	0.08	-	0.10

Competitive Comparison of BioLight Life Sciences's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, BioLight Life Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioLight Life Sciences's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLight Life Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioLight Life Sciences's Cyclically Adjusted PB Ratio falls into.

BioLight Life Sciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BioLight Life Sciences's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, BioLight Life Sciences's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book	=	Book Value per Share	/	CPI of Dec23 (Change)	*	Current CPI (Dec23)
	=	0.161	/	129.4194	*	129.4194
	=	0.161

Current CPI (Dec23) = 129.4194.

BioLight Life Sciences Annual Data

	Book Value per Share	CPI	Adj_Book
201412	0.154	99.070	0.201
201512	0.187	99.792	0.243
201612	0.059	101.863	0.075
201712	0.033	104.011	0.041
201812	0.445	105.998	0.543
201912	0.373	108.420	0.445
202012	0.320	109.897	0.377
202112	0.328	117.630	0.361
202212	0.288	125.222	0.298
202312	0.161	129.419	0.161

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

BioLight Life Sciences (NAS:BOLT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.

BioLight Life Sciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLight Life Sciences (BioLight Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (NAS:BOLT) » Definitions » Cyclically Adjusted PB Ratio

Comparable Companies

Traded in Other Exchanges

BOLT:Israel

Address

Kiryat Atidim, Building 7, Entrance 1, 2nd Floor, Tel-Aviv, ISR, 6158101

Website

http://www.bio-light.co.il

BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.